Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
PHAT - Phathom Pharmaceuticals, Inc.
Market Cap 803.81M P/E - EPS this Y -32.30% Ern Qtrly Grth -
Income -246.63M Forward P/E -2.69 EPS next Y 26.90% 50D Avg Chg 8.00%
Sales 2.59M PEG - EPS past 5Y - 200D Avg Chg 34.00%
Dividend N/A Price/Book N/A EPS next 5Y - 52W High Chg -9.00%
Recommedations 1.80 Quick Ratio 7.50 Shares Outstanding 58.54M 52W Low Chg 144.00%
Insider Own 8.92% ROA -51.75% Shares Float 43.27M Beta 0.67
Inst Own 90.38% ROE - Shares Shorted/Prior 11.80M/10.65M Price 14.25
Gross Margin 77.14% Profit Margin - Avg. Volume 350,793 Target Price 22.88
Oper. Margin -3,658.68% Earnings Date Aug 8 Volume 908,264 Change -5.63%
Healthcare | Biotechnology | United States
About Phathom Pharmaceuticals, Inc.

Phathom Pharmaceuticals, Inc., biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada for an investigational potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also developing vonoprazan for the treatment of erosive gastroesophageal reflux disease; and in combination with antibiotics for the treatment of Helicobacter pylori infection. The company was incorporated in 2018 and is headquartered in Florham Park, New Jersey.

Phathom Pharmaceuticals, Inc. News
05/15/24 Phathom Pharmaceuticals to Present VOQUEZNA® (vonoprazan) Data at DDW 2024 Annual Meeting
05/13/24 Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Q1 2024 Earnings Call Transcript
05/10/24 The 3 Best Healthcare Stocks to Buy in May 2024
05/09/24 Phathom Pharmaceuticals, Inc. (PHAT) Reports Q1 Loss, Lags Revenue Estimates
05/09/24 Phathom Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
04/29/24 Phathom Pharmaceuticals to Report First Quarter 2024 Financial Results and Provide Business Update on Thursday, May 9, 2024
04/19/24 MasterCraft Boat, SentinelOne, and More Stocks See Action From Activist Investors
04/19/24 12 Most Shorted Stocks in 2024
04/05/24 ARS Pharmaceuticals, Nuvalent, and More Stocks See Action From Activist Investors
04/03/24 Phathom Pharmaceuticals to Participate in the 23rd Annual Needham Virtual Healthcare Conference
03/26/24 Phathom Pharmaceuticals Launches Direct-to-Consumer Campaign, “VOQUEZNA Can Kick Some Acid”
03/08/24 Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Q4 2023 Earnings Call Transcript
03/08/24 Q4 2023 Phathom Pharmaceuticals Inc Earnings Call
03/07/24 Phathom Pharmaceuticals Inc (PHAT) Reports Q4 and Full Year 2023 Financials, Eyes Growth with ...
03/07/24 Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
02/29/24 Phathom Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Thursday, March 7, 2024
02/13/24 Phathom Pharmaceuticals Announces VOQUEZNA® (vonoprazan) Tablets for Erosive GERD and Associated Heartburn Added to Express Scripts National Formularies for Commercial Patients
01/31/24 Phathom Pharmaceuticals to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
01/28/24 With 47% ownership, Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) has piqued the interest of institutional investors
12/14/23 Phathom Pharmaceuticals Announces Expansion of Existing Loan and Security Agreement with Hercules Capital
PHAT Chatroom

User Image Creamcheeze Posted - 16 hours ago

$PHAT Poster presentation pretty much seals the July 19 PDUFA decision

User Image Jacobi Posted - 23 hours ago

$PHAT algos keep dropping it and I keep hitting the ask and then sell some on the mini pump.

User Image BioPulse Posted - 1 day ago

@BioPulse Reasons I like $PHAT: July 17th PDUFA - Big Event for Company Short Interest 42% of Float 👀 Trading at circa 2X Cash👀 August Call Activity > 5k contracts 👀 Analyst Consensus >$24👀 Institutional Ownership >90% 👀 Cash Runway through to ‘25 👀 Was long anyway but with MEME🔥

User Image Ecryder Posted - 1 day ago

$PHAT nice. Just like to see it continue tomorrow

User Image DMAY0 Posted - 1 day ago

@Armymike1981 what are you into these days loll. i have been riding $PHAT

User Image FetchDog Posted - 2 days ago

$PHAT Why is this up today? Chart looked like it was going down. Really hard to predict what this stock will do from one day to the next.

User Image RonIsWrong Posted - 2 days ago

@mh_aina $PHAT scripts

User Image mh_aina Posted - 2 days ago

$PHAT @RonIsWrong sir you got the scripts for last Friday please?

User Image CHCInvestments Posted - 2 days ago

$PHAT Still patiently waiting......if this gets good news on July 19, open the flood gates because this will fly. Is short % really 40%?

User Image DMAY0 Posted - 2 days ago

$PHAT i think were back baby!

User Image Creamcheeze Posted - 4 days ago

$PHAT Sad to see us languish under a revolutionary drug to the market... July PDUFA might not be what we expect as be a catalyst considering EE PDUFA sent us downwards... not to mention the macroeconomic factors at play. I think we're stuck for a long time

User Image DMAY0 Posted - 5 days ago

$PHAT must be pay day for the employees who get stock options. hang in there. i am.

User Image Ecryder Posted - 5 days ago

$PHAT jeez,and this after a half decent earnings….

User Image asm123 Posted - 5 days ago

$PHAT Takeda trying to cash out? Nothing I can see that would justify the drop.

User Image DMAY0 Posted - 5 days ago

$PHAT ???

User Image DMAY0 Posted - 5 days ago

$PHAT whats our day going to be like….💪🏻🇺🇸

User Image toddk18 Posted - 6 days ago

$PHAT let’s see what Paul Choi comes out with.

User Image Longboardsoul Posted - 6 days ago

$PHAT Zero shares available to short!

User Image Ecryder Posted - 6 days ago

$PHAT Really?

User Image Doorkey Posted - 6 days ago

$PHAT LFG PHATTY!

User Image sunset_PARK Posted - 6 days ago

$PHAT if I understand it correctly, they improved the demand/dispensed-filled rate, when compared to last er, from 3.68 to 2.46. Someone from the pharmaceutical industries, please provide more insight

User Image CH_Expat Posted - 6 days ago

$PHAT Strange price action here. Probably best to just hold. The squeeze could come delayed.

User Image 911Turbo Posted - 6 days ago

$PHAT price is all over the places. Weird stock

User Image _www_larval_com_ Posted - 1 week ago

$PHAT just soared 7% higher to 7% (~169Kv) moments ago, 05/17 options, follow for more volatility.

User Image Jacobi Posted - 1 week ago

$PHAT bought more

User Image Hamzarr Posted - 1 week ago

$PHAT

User Image CH_Expat Posted - 1 week ago

$PHAT What was Needham expecting in Revenue? 1.5 Million?

User Image epsguid Posted - 1 week ago

$PHAT reported a loss of $1.42, consensus was ($1.43) via @eWhispers #epsbeat http://eps.sh/d/phat

User Image Lolichocho Posted - 1 week ago

$PHAT and the market reacts wildly with....0 volume...

User Image CH_Expat Posted - 1 week ago

$PHAT 1,9 Million revenue, not bad, not great.

Analyst Ratings
Needham Buy May 10, 24
HC Wainwright & Co. Buy May 10, 24
Needham Buy May 9, 24
Needham Buy May 8, 24
Needham Buy May 3, 24
Stifel Buy May 3, 24
Needham Buy Apr 26, 24
Needham Buy Apr 19, 24
Needham Buy Apr 12, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
TAKEDA PHARMACEUTICAL CO LTD 10% Owner 10% Owner Jan 24 Sell 8.10 3,703,703 29,999,994 3,755,583 01/25/24
Henderson Molly CFO and CBO CFO and CBO Jan 18 Sell 7.7533 6,307 48,900 98,698 01/22/24
Parikh Asit Director Director Nov 06 Buy 7.87 7,500 59,025 55,000 11/08/23
Henderson Molly CFO and CBO CFO and CBO Jun 02 Sell 11.4121 1,960 22,368 68,506 06/05/23
Henderson Molly CFO and CBO CFO and CBO May 22 Sell 12.8744 2,110 27,165 70,466 05/23/23
Curran Terrie President and Chief.. President and Chief Executive Mar 01 Sell 8.5411 1,436 12,265 175,371 03/03/23
Curran Terrie President and Chief.. President and Chief Executive Jan 19 Sell 8.2 5,821 47,732 176,807 01/20/23
Nabulsi Azmi Chief Operating Offi.. Chief Operating Officer May 16 Buy 8.1644 20,000 163,288 785,700 05/16/22
Curran Terrie President and Chief.. President and Chief Executive May 13 Buy 7.4066 20,500 151,835 64,595 05/16/22
Parikh Asit Director Director May 12 Buy 8.00 12,500 100,000 12,500 05/16/22
TAKEDA PHARMACEUTICAL CO LTD 10% Owner 10% Owner Mar 14 Sell 19 18 342 7,459,286 03/16/22
COLA MICHAEL F Director Director Oct 29 Buy 19.00 9,798 186,162 9,798 02/18/22
TAKEDA PHARMACEUTICAL CO LTD 10% Owner 10% Owner Nov 04 Sell 19.93 1,000,001 19,930,020 100,000 11/08/21
Socks David A Director Director Oct 07 Sell 32.36 18,000 582,480 1,211,346 10/08/21
Socks David A Director Director Aug 18 Sell 30.98 18,000 557,640 1,247,346 08/18/21
Socks David A Director Director Jun 29 Sell 34.39 40,000 1,375,600 1,260,945 06/29/21
TAKEDA PHARMACEUTICAL CO LTD 10% Owner 10% Owner Jun 29 Sell 35.54 24,501 870,766 882,240 06/29/21
TAKEDA PHARMACEUTICAL CO LTD 10% Owner 10% Owner Jun 25 Sell 35.07 11,048 387,453 906,741 06/25/21
TAKEDA PHARMACEUTICAL CO LTD 10% Owner 10% Owner Jun 23 Sell 35.16 9,394 330,293 917,789 06/23/21
TAKEDA PHARMACEUTICAL CO LTD 10% Owner 10% Owner Jun 11 Sell 35.21 3,293 115,947 938,712 06/11/21
TAKEDA PHARMACEUTICAL CO LTD 10% Owner 10% Owner Jun 09 Sell 35.03 2,364 82,811 942,005 06/09/21
TAKEDA PHARMACEUTICAL CO LTD 10% Owner 10% Owner Jun 02 Sell 36.21 20,116 728,400 948,669 06/02/21
TAKEDA PHARMACEUTICAL CO LTD 10% Owner 10% Owner May 28 Sell 36.98 20,811 769,591 968,785 05/28/21
TAKEDA PHARMACEUTICAL CO LTD 10% Owner 10% Owner May 26 Sell 36.11 21,541 777,846 989,596 05/26/21
TAKEDA PHARMACEUTICAL CO LTD 10% Owner 10% Owner May 24 Sell 35.42 18,746 663,983 1,011,137 05/24/21
Socks David A Director Director May 21 Sell 33.68 40,000 1,347,200 1,300,945 05/21/21
TAKEDA PHARMACEUTICAL CO LTD 10% Owner 10% Owner May 14 Sell 35.59 11,876 422,667 1,029,983 05/14/21
TAKEDA PHARMACEUTICAL CO LTD 10% Owner 10% Owner May 07 Sell 35.08 7,138 250,401 1,042,870 05/07/21
Nabulsi Azmi Chief Operating Offi.. Chief Operating Officer Apr 05 Sell 36.91 14,500 535,195 780,200 04/05/21
Curran Terrie President and Chief.. President and Chief Executive Mar 23 Option 6.95 11,513 80,015 11,513 03/23/21
Curran Terrie President and Chief.. President and Chief Executive Mar 23 Sell 43.66 11,513 502,658 03/23/21
Socks David A Director Director Jan 13 Sell 35.62 40,000 1,424,800 1,532,945 01/13/21
Nabulsi Azmi Chief Operating Offi.. Chief Operating Officer Jan 05 Sell 33.82 14,500 490,390 823,700 01/05/21
Socks David A Director Director Dec 18 Sell 44.95 79,658 3,580,627 1,572,945 12/18/20
Socks David A Director Director Nov 12 Sell 41.45 30,342 1,257,676 1,652,603 11/12/20
Nabulsi Azmi Chief Operating Offi.. Chief Operating Officer Nov 03 Sell 36.83 14,500 534,035 852,700 11/03/20